+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceruloplasmin Test"

2022-2026 Global Ceruloplasmin Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2022-2026 Global Ceruloplasmin Testing in 90 Countries - Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • March 2022
  • Global
From
2020 Ceruloplasmin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Ceruloplasmin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Ceruloplasmin Test is a diagnostic test used to measure the amount of ceruloplasmin, a protein found in the blood, in order to diagnose certain conditions. It is used to diagnose Wilson's disease, a rare genetic disorder that affects copper metabolism, as well as other conditions such as liver disease, anemia, and certain types of cancer. The test is typically performed in a laboratory setting and results are usually available within a few days. The Ceruloplasmin Test market is composed of a variety of companies that provide diagnostic testing services. These companies include Quest Diagnostics, LabCorp, Mayo Clinic Laboratories, and ARUP Laboratories. Other companies in the market include Bio-Rad Laboratories, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more